Effectiveness of total hip arthroplasty versus non-surgery on patient-reported hip function at 3 months: a target trial emulation study of patients with osteoarthritis
DOI:
https://doi.org/10.2340/17453674.2025.43332Keywords:
Arthroplasty, Hip, Target Trial EmulationAbstract
Background and purpose: This study introduces an innovative research design in the field of orthopedics, using a target trial emulation approach. We aimed to assess the causal effects of total hip arthroplasty (THA) compared with nonoperative treatment in reducing patient-reported hip disability at 3 months in patients with osteoarthritis, using real-world data.
Methods: We emulated a target trial using real-world data of 2 Dutch hospitals between April 2020 and January 2022. Patients diagnosed with hip osteoarthritis and eligible for primary THA were included in the study. During the COVID-19 pandemic, THA was often cancelled due to external factors (i.e., limited operating room capacity, or surgeon unavailable due to quarantine rules), resulting in an arbitrary allocation of patients to THA (n = 132) or non-THA (n = 60). We compared changes in hip disability, measured using the Hip disability and Osteoarthritis Outcome Score Physical function Short form (HOOS-PS), between the THA group at 3 months postoperatively and the non-THA group at ≥3 months post waiting-list. Linear regression analysis, adjusting for potential confounders, was used to compare between-group differences.
Results: THA showed preferable outcomes compared with non-THA, indicated by a difference of –33 points (95% confidence interval [CI] –37 to –28) on the HOOS-PS. Patients in the THA group demonstrated a clinically significant improvement in hip function, with a mean change of –27 points (CI –31 to –24), while the control group showed no improvement with a mean change of 7 points (CI 3–11) on the HOOS-PS.
Conclusion: THA significantly improves hip function in osteoarthritis patients, surpassing the outcomes observed in the non-surgery group.
Downloads
References
LROI. Dutch Arthroplasty Register (LROI) Annual Report 2024. Available from: https://www.lroi.nl/media/prqogokg/pdf-lroi-report-2024.pdf.
NJR. National Joint Registry (NJR) – 19th Annual Report 2022. Available from: https://wwwnjrcentreorguk/njr-annual-report-2022/ 2022.
Yan L, Ge L, Dong S, Saluja K, Li D, Reddy K S, et al. Evaluation of comparative efficacy and safety of surgical approaches for total hip arthroplasty: a systematic review and network meta-analysis. JAMA Netw Open 2023; 6: e2253942. doi: 10.1001/jamanetworkopen.2022.53942. DOI: https://doi.org/10.1001/jamanetworkopen.2022.53942
Blom A W, Donovan R L, Beswick A D, Whitehouse M R, Kunutsor S K. Common elective orthopaedic procedures and their clinical effectiveness: umbrella review of level 1 evidence. BMJ 2021; 374: n1511. doi: 10.1136/bmj.n1511. DOI: https://doi.org/10.1136/bmj.n1511
Groenwold R H H. Trial emulation and real-world evidence. JAMA Netw Open 2021; 4: e213845. doi: 10.1001/jamanetworkopen.2021.3845. DOI: https://doi.org/10.1001/jamanetworkopen.2021.3845
Hernan M A, Robins J M. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 2016; 183: 758-764. doi: 10.1093/aje/kwv254. DOI: https://doi.org/10.1093/aje/kwv254
RIVM. RIVM report 2022-0053 – Health related consequences of postponed surgeries during the COVID pandemic. Available from: https://wwwrivmnl/bibliotheek/rapporten/2022-0053pdf 2022.
Hansford H J, Cashin A G, Jones M D, Swanson S A, Islam N, Douglas S R G, et al. Reporting of observational studies explicitly aiming to emulate randomized trials: a systematic review. JAMA Netw Open 2023; 6: e2336023. doi: 10.1001/jamanetworkopen.2023.36023. DOI: https://doi.org/10.1001/jamanetworkopen.2023.36023
Hernan M A, Wang W, Leaf D E. Target trial emulation: a framework for causal inference from observational data. JAMA 2022; 328: 2446-7. doi: 10.1001/jama.2022.21383. DOI: https://doi.org/10.1001/jama.2022.21383
Smith T O, Hawker G A, Hunter D J, March L M, Boers M, Shea B J, et al. The OMERACT-OARSI core domain set for measurement in clinical trials of hip and/or knee osteoarthritis. J Rheumatol 2019; 46: 981-9. doi: 10.3899/jrheum.181194. DOI: https://doi.org/10.1093/rheumatology/kez108.060
Paulsen A, Roos E M, Pedersen A B, Overgaard S. Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively. Acta Orthop 2014; 85: 39-48. doi: 10.3109/17453674.2013.867782. DOI: https://doi.org/10.3109/17453674.2013.867782
Austin P C, White I R, Lee D S, van Buuren S. Missing data in clinical research: a tutorial on multiple imputation. Can J Cardiol 2021; 37: 1322-1331. doi: 10.1016/j.cjca.2020.11.010. DOI: https://doi.org/10.1016/j.cjca.2020.11.010
Pronk Y, van der Weegen W, Schreurs B W, Pilot P. Quality of total hip arthroplasty health care based on four years of patient-reported outcomes in the Netherlands. Health Qual Life Outcomes 2023; 21: 24. doi: 10.1186/s12955-023-02104-2. DOI: https://doi.org/10.1186/s12955-023-02104-2
Ingelsrud L H, Wilkinson J M, Overgaard S, Rolfson O, Hallstrom B, Navarro R A, et al. How do patient-reported outcome scores in international hip and knee arthroplasty registries compare? Clin Orthop Relat Res 2022; 480: 1884-96. doi: 10.1097/CORR.0000000000002306. DOI: https://doi.org/10.1097/CORR.0000000000002306
Frydendal T, Christensen R, Mechlenburg I, Mikkelsen L R, Varnum C, Graversen A E, et al. Total hip replacement or resistance training for severe hip osteoarthritis. N Engl J Med 2024; 391: 1610-20. doi: 10.1056/NEJMoa2400141. DOI: https://doi.org/10.1056/NEJMoa2400141
Matthay E C, Hagan E, Gottlieb L M, Tan M L, Vlahov D, Adler N E, et al. Alternative causal inference methods in population health research: evaluating tradeoffs and triangulating evidence. SSM Popul Health 2020; 10: 100526. doi: 10.1016/j.ssmph.2019.100526. DOI: https://doi.org/10.1016/j.ssmph.2019.100526
Cunningham J A, Kypri K, McCambridge J. Exploratory randomized controlled trial evaluating the impact of a waiting list control design. BMC Med Res Methodol 2013; 13: 150. doi: 10.1186/1471-2288-13-150. DOI: https://doi.org/10.1186/1471-2288-13-150
Dorleijn D M J, Luijsterburg P A J, Reijman M, Kloppenburg M, Verhaar J A N, Bindels P J E, et al. Intramuscular glucocorticoid injection versus placebo injection in hip osteoarthritis: a 12-week blinded randomised controlled trial. Ann Rheum Dis 2018; 77: 875-82. doi: 10.1136/annrheumdis-2017-212628. DOI: https://doi.org/10.1136/annrheumdis-2017-212628
Teirlinck C H, Luijsterburg P A, Dekker J, Bohnen A M, Verhaar J A, Koopmanschap M A, et al. Effectiveness of exercise therapy added to general practitioner care in patients with hip osteoarthritis: a pragmatic randomized controlled trial. Osteoarthritis Cartilage 2016; 24: 82-90. doi: 10.1016/j.joca.2015.07.023. DOI: https://doi.org/10.1016/j.joca.2015.07.023
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Amanda D Klaassen, Wiard Jorritsma, Nienke W Willigenburg, Carina L E Gerritsma, Bas L E F Ten Have, Dirk Jan F Moojen, Maaike G J Gademan, Rolf H H Groenwold, Rudolf W Poolman
This work is licensed under a Creative Commons Attribution 4.0 International License.
